Recall Register

Food, drugs, devices › Terumo Cardiovascular Systems Corporation

Device recall: Terumo Pall AL6X Arterial Blood Line Filter, labeled in part Terumo Cardiovascular Systems Corporation, packaged as part

FDA enforcement event 65981 · Class II · initiated 26 Jul 2013 · status Terminated · terminated 28 Jul 2015

DeviceVoluntary: Firm initiated1 product recordElkton, MD

Terumo Cardiovascular Systems Corporation (Elkton, MD) initiated this device recall on 26 Jul 2013; FDA lists 1 product record under event 65981, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 90% of the 1,236 device enforcement events initiated in 2013 carry the same class.

Status: Terminated, terminated 28 Jul 2015. Initiation: voluntary: firm initiated. Terumo Cardiovascular Systems Corporation has 73 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Terumo Cardiovascular Systems Corporation, Elkton, MD.

Reason for recall

"Medical device used in cardiovascular procedures is defective."

Distribution

"Nationwide Distribution including WA, IN, OK, TX, MI, CA, NY, CT, AZ, FL, WV, NC, VA, PA, TN, GA, AL, MA, SC, OH, MS, MO, SD, WI, AR, AND NV."

Product records

Recall numberProductQuantityClassStatusReport date
Z-2261-2013Terumo Pall AL6X Arterial Blood Line Filter, labeled in part Terumo Cardiovascular Systems Corporation, packaged as part of a Terumo Cardiovascular Procedure Kit or as a single, sterile filter unit Single/Sterile Terumo Pall AL6X Arterial Filter: The Terumo Pall AL6X Arterial Filter is indicated for use in…15,817 filtersClass IITerminated2 Oct 2013

Context

90%of 2013 device events are Class II1,236 events that year
1product record in this eventfirm median: 2
73events on this register for the firm

Other enforcement events for Terumo Cardiovascular Systems Corporation

InitiatedProduct (first record)TypeClassRecords
28 May 2025CDI OneView System BPM Probe: Cat. No. CDI753 - CDI OneView BPM Probe, Cat. No. CDI753TK - CDI OneView BPM Probe Trial KDeviceClass II1
3 Mar 2025Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe, Catalog Number REF CD1754DeviceClass II1
20 Feb 2024Cardiovascular Procedure Kits that include High Crack Check Valve PN 205307A Part Number: 6375 16010 62974 65246 66312 6DeviceClass II1
1 Mar 2023CAPIOX RX15 Hollow Fiber Oxygenator, Catalog Number 3CX*RX15RE30DeviceClass II3
8 Jun 2021Terumo Advanced Perfusion System 1 Electronic Patient Gas System Catalog #: 801188DeviceClass II1
16 Apr 2021The Terumo HX2 Temperature Management System provides temperature control of two independent water circuits that directlDeviceClass II3
2 Mar 2021Consist of a distal connection mechanism (either standard Terumo Ball Quick Connect or Terumo Shaft Quick Connect), an aDeviceClass II1
11 Nov 2020(1) Capiox FX25 (West) Advance Oxygenator- with left port, 4-liter Reservoir, XC modified to Advance, Sterile Catalog NuDeviceClass II1
25 Aug 2020Terumo Advanced Perfusion System 1 Ultrasonic Air Sensor 3/8x3/32, Catalog Number 5773 - Product Usage: intended for useDeviceClass II3
10 Jan 2020Terumo Advanced Perfusion System 1 Roller Pump, 4 Inch, Catalog Number 816570 - Product Usage: is indicated for use for DeviceClass II4

All 73 events for Terumo Cardiovascular Systems Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Medical device used in cardiovascular procedures is defective."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide Distribution including WA, IN, OK, TX, MI, CA, NY, CT, AZ, FL, WV, NC, VA, PA, TN, GA, AL, MA, SC, OH, MS, MO, SD, WI, AR, AND NV."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 28 Jul 2015. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.